Seres Therapeutics, Inc. Payments of Stock Issuance Costs
Seres Therapeutics, Inc. (MCRB) reported Payments of Stock Issuance Costs of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-03-13
- Seres Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2022-12-31 was $0.00.
- Seres Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2022-09-30 was $3.28M.
- Seres Therapeutics, Inc. payments of stock issuance costs for fiscal 2022 was $3.28M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $3.28M derived: sum of 2 quarters · filed 2025-03-13 | $3.28M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $3.28M 10-Q · filed 2023-11-02 | $3.28M 10-Q · filed 2023-11-02 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |